Related Articles
Molecular, biological characterization and drug sensitivity of chidamide‑resistant non‑small cell lung cancer cells
Interleukin‑1β weakens paclitaxel sensitivity through regulating autophagy in the non‑small cell lung cancer cell line A549
NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer
F10, a novel hydatidiform mole-associated gene, inhibits the paclitaxel sensitivity of A549 lung cancer cells by downregulating BAX and caspase-3
ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel